NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Mold-Tek Technologies Shareholders Approve Preferential Equity Issue with 100% Majority
Mold-Tek Technologies Limited has received near-unanimous shareholder approval for the issuance of equity shares on a preferential basis during its Extraordinary General Meeting held on March 30, 2026. The special resolution was passed with 15,371,048 votes in favor, representing approximately 100% of the valid votes cast. This approval allows the company to proceed with its capital-raising plans through the targeted issuance of new equity. The strong mandate from shareholders indicates significant support for the company's strategic financial objectives.
முக்கிய அம்சங்கள்
Special Resolution for the issue of equity shares on a preferential basis was passed with requisite majority.A total of 15,371,048 votes (100% of valid votes) were cast in favor of the resolution.Only 2 votes from a single member were recorded against the proposal.100 members participated in the voting process via remote e-voting and electronic voting at the EGM.The voting results were verified by Scrutinizer Ashish Kumar Gaggar and submitted to the exchanges on April 1, 2026.
👀 கவனிக்க வேண்டியவை
Investors should monitor subsequent filings for details on the issue price and the specific entities receiving the shares to evaluate potential dilution and strategic benefits. The overwhelming shareholder support is a positive sign of confidence in the management's growth plans.
Mold-Tek Technologies Approves Preferential Issue of Equity Shares at EGM
Mold-Tek Technologies Limited held an Extraordinary General Meeting (EGM) on March 30, 2026, to seek shareholder approval for a preferential issue of equity shares. The meeting, attended by 56 members, focused on this special resolution aimed at raising capital for the company. While specific pricing and allotment details were not disclosed in this summary, the Chairman provided an overview of the strategic intent behind the issue. The final approval depends on the voting results, which will be disclosed separately.
முக்கிய அம்சங்கள்
Special Resolution proposed for the issuance of equity shares on a preferential basis.The EGM was attended by 56 members via video conferencing on March 30, 2026.Remote e-voting was conducted between March 26 and March 29, 2026, with a cut-off date of March 23, 2026.The meeting concluded in 36 minutes after addressing shareholder queries regarding the fundraise.
👀 கவனிக்க வேண்டியவை
Investors should monitor the upcoming disclosure of voting results and specific details regarding the issue price and allottees. This capital infusion is a key indicator of the company's growth or deleveraging plans.
Mold-Tek Technologies to Raise ₹4.76 Crore via Preferential Issue to US-based Investor
Mold-Tek Technologies Limited has called for an Extraordinary General Meeting (EGM) on March 30, 2026, to approve a preferential issue of equity shares. The company intends to issue 2,90,000 equity shares at a price of ₹164 per share to Mr. Richard Leon Cannyn, a non-promoter individual. This transaction will result in a capital infusion of approximately ₹4.76 Crores. The issue price represents a face value of ₹2 and a premium of ₹162 per share.
முக்கிய அம்சங்கள்
Preferential allotment of 2,90,000 equity shares to a non-promoter individual investor.Total fundraise amount is approximately ₹4.756 Crores at an issue price of ₹164 per share.Relevant date for price determination was set as February 27, 2026.EGM scheduled for March 30, 2026, with remote e-voting available from March 26 to March 29, 2026.The shares issued will be subject to a statutory lock-in period as per SEBI ICDR Regulations.
👀 கவனிக்க வேண்டியவை
Investors should note the entry of a foreign individual investor and monitor the company's disclosure regarding the specific use of these funds for growth or debt reduction. The equity dilution from this specific issue is relatively small but indicates management's intent to bring in external capital.
Mold-Tek Technologies to Raise Rs 4.76 Crore via Preferential Issue at Rs 164/Share
Mold-Tek Technologies has approved the issuance of 2,90,000 equity shares on a preferential basis to a non-promoter investor, Mr. Richard Leon Cannyn. The shares are priced at Rs 164 each, representing a significant premium over the face value of Rs 2. The total fundraise amounts to approximately Rs 4.76 crore, which will result in the investor holding a 0.997% stake in the company post-allotment. An Extraordinary General Meeting (EGM) is scheduled for March 30, 2026, to seek shareholder approval for the transaction.
முக்கிய அம்சங்கள்
Issuance of up to 2,90,000 equity shares at an issue price of Rs 164 per share.Total fundraise amount aggregates to Rs 4,75,60,000 from a single non-promoter investor.The investor, Richard Leon Cannyn, will hold a 0.997% stake in the company post-issue.Relevant date for pricing as per SEBI ICDR Regulations is February 27, 2026.Extraordinary General Meeting (EGM) to be held on March 30, 2026, for shareholder approval.
👀 கவனிக்க வேண்டியவை
Investors should note the equity dilution of approximately 1% and monitor how the company intends to utilize these funds for growth. The preferential pricing provides a benchmark for the company's current valuation assessment by external investors.
Meghmani Organics Subsidiary Kilburn Chemicals Assigned IND BBB Rating with Negative Watch
India Ratings & Research has assigned credit ratings to Kilburn Chemicals Limited, a subsidiary of Meghmani Organics Limited. The ratings cover bank facilities totaling INR 2,742 million, including a term loan of INR 1,992 million and working capital limits of INR 750 million. Notably, all rated facilities have been placed on 'Rating Watch with Negative Implications,' signaling potential downward pressure on the credit profile. Investors should monitor the subsidiary's operational performance as it may impact the parent company's consolidated financial health.
முக்கிய அம்சங்கள்
India Ratings assigned 'IND BBB' rating to Kilburn Chemicals' INR 1,992 million term loan.Working capital limits of INR 750 million received 'IND BBB' and 'IND A3+' ratings.Total rated bank facilities for the subsidiary amount to INR 2,742 million.All facilities are placed on 'Rating Watch with Negative Implications' as of February 27, 2026.
👀 கவனிக்க வேண்டியவை
Investors should monitor the reasons behind the 'Negative Implications' watch, as a potential downgrade could increase borrowing costs for the subsidiary and affect the parent company's valuation.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Mold-Tek Technologies reported a stellar Q3 FY26 with profits growing over sixfold year-on-year and 20.2% sequentially. The company is aggressively restructuring its underperforming automotive division, reducing headcount from 160 to 60 to focus on high-growth areas like transmission poles and data centers. Management has set a revenue target of $25 million (approx. INR 225-230 crores) for next year, driven by the integration of the Beryl acquisition and offshoring benefits. The company aims for a 20-25% CAGR over the next 3-5 years through organic growth and further strategic acquisitions.
முக்கிய அம்சங்கள்
Q3 FY26 profits increased by more than 6x YoY and 20.2% on a QoQ basis.Revenue guidance for FY27 set at $25 million, representing a significant jump from the estimated INR 180 crores in FY26.Beryl acquisition contributed $137,000 (INR 1.25 crores) in operating profit during its first two months of operations.Mechanical Engineering (MES) division is being downsized from 160 to 60 members to eliminate losses and improve efficiency.Data center projects are expected to contribute $2.5 million to $3.5 million in incremental annual revenue across civil and mechanical segments.
👀 கவனிக்க வேண்டியவை
Investors should view the aggressive cost-cutting in the automotive segment and the successful integration of Beryl as strong catalysts for margin expansion. Monitor the company's ability to transition Beryl's high-cost US operations to its Indian back-office to realize projected profitability gains.
Mold-Tek Packaging Q3 FY26: EBITDA Up 14%, Targets ₹1,000 Cr Revenue in FY27
Mold-Tek Packaging reported a 14% YoY EBITDA growth in Q3 FY26, despite the quarter being seasonally weak. The company is consolidating its Hyderabad operations from five units into two to enhance operational efficiency and cost control, with benefits expected from next quarter. Management has set an ambitious revenue target of over ₹1,000 crore for FY27, driven by a 12-15% volume growth outlook. The Pharma segment remains a key growth lever, with a target of ₹50-55 crore for the next fiscal year.
முக்கிய அம்சங்கள்
9M FY26 EBITDA grew by 20% YoY, while Q3 volumes increased by 6%.Revised FY26 volume guidance to 42,500 tons (11% growth) due to extended monsoons.Pharma segment on track for ₹35 crore in FY26 with 25+ clients cleared for production.Manufacturing consolidation in Hyderabad to be completed by March 2026 to improve margins.Projected FY26 PAT of ₹73-75 crore, representing a 20% year-on-year growth.
👀 கவனிக்க வேண்டியவை
Investors should focus on the company's transition into high-margin Pharma packaging and the efficiency gains from plant consolidation. The ₹1,000 crore revenue guidance for FY27 suggests strong management confidence in volume recovery.
Anmol India Q3 Net Profit Surges to ₹2.94 Cr from ₹0.38 Cr YoY; Revenue Up 20%
Anmol India Limited reported a strong performance for the quarter ended December 31, 2025, with revenue from operations reaching ₹303.16 crore, a 19.7% increase compared to ₹253.32 crore in the same quarter last year. The net profit saw a massive surge to ₹2.94 crore from just ₹0.38 crore in Q3 FY25, indicating a significant improvement in margins. On a nine-month basis, the company's PAT grew to ₹8.79 crore from ₹5.39 crore in the previous year. The basic EPS for the quarter improved significantly to ₹0.52 from ₹0.07 YoY.
முக்கிய அம்சங்கள்
Revenue from operations grew 19.7% YoY to ₹303.16 crore in Q3 FY26.Net profit (PAT) surged by over 670% YoY to ₹2.94 crore from ₹0.38 crore.Profit Before Tax (PBT) increased to ₹3.93 crore compared to ₹0.51 crore in the year-ago period.Nine-month (9M FY26) revenue stood at ₹1,108.06 crore, up from ₹960.03 crore in 9M FY25.Basic EPS for the quarter rose to ₹0.52 from ₹0.01 in the preceding quarter (Q2 FY26).
👀 கவனிக்க வேண்டியவை
Investors should monitor if the company can sustain these improved margins in the coming quarters, as the sharp turnaround in profitability is a strong positive signal. The stock may see positive momentum given the significant growth in both top-line and bottom-line figures.
Mold-Tek Tech Q3 PAT Surges 617% YoY to ₹3.89 Cr; Revenue Up 57%
Mold-Tek Technologies reported a robust recovery in Q3 FY26, with consolidated revenue growing 56.7% YoY to ₹52.67 crore. Net profit witnessed a massive surge of 617% YoY, reaching ₹3.89 crore compared to a low base of ₹0.54 crore in the previous year. While the quarterly performance is strong, the nine-month PAT of ₹7.81 crore still lags behind the ₹13.73 crore earned in the same period last year. The company's US-based subsidiaries remain integral to its consolidated performance.
முக்கிய அம்சங்கள்
Consolidated Revenue from operations grew 56.7% YoY to ₹5,266.70 lakhs in Q3 FY26.Consolidated Net Profit (PAT) jumped to ₹388.85 lakhs from ₹54.19 lakhs in the year-ago quarter.Earnings Per Share (EPS) for the quarter improved significantly to ₹1.35 from ₹0.19 YoY.Nine-month consolidated revenue stands at ₹12,618.92 lakhs, up from ₹11,597.25 lakhs YoY.Employee benefit expenses increased to ₹3,758.74 lakhs this quarter, up from ₹2,662.18 lakhs YoY.
👀 கவனிக்க வேண்டியவை
The sharp YoY and QoQ recovery in profitability indicates a strong turnaround in business momentum. Investors should monitor the sustainability of this margin expansion in upcoming quarters to see if the 9-month profit gap can be narrowed.
Mold-Tek Packaging 9M FY26 EBITDA Up 20% to ₹125.55 Cr; Pharma Volume Surges 190%
Mold-Tek Packaging reported a 12% YoY revenue growth to ₹648.75 crore for 9M FY26, while PAT rose 18% to ₹52.23 crore. The company demonstrated strong operational efficiency with EBITDA margins expanding to 19.35% and EBITDA per kg rising 10% to ₹40.24. The Pharma vertical is emerging as a high-growth driver, recording a 190% volume jump in Q3 FY26. Furthermore, a new MoU for UK-based high-precision closures offers a ₹250 crore revenue opportunity over five years.
முக்கிய அம்சங்கள்
9M FY26 EBITDA grew 20% YoY to ₹125.55 crore with margins improving by 125 bps to 19.35%Pharma segment Q3 volume grew 190% YoY, contributing ₹10.81 crore in quarterly salesStrategic MoU with Vibe Generation Holdings (UK) targets ₹250 crore revenue over 5 years9M FY26 Sales Volume reached 31,203 MT, a 9% increase over the previous yearEBITDA per KG increased from ₹36.73 to ₹40.24, indicating a shift towards high-value products
👀 கவனிக்க வேண்டியவை
Investors should view the margin expansion and rapid Pharma growth as strong indicators of successful business diversification. The stock remains a quality play on rigid packaging with significant upside potential from the new international partnership.
Mold-Tek Packaging Reports Financial Results for Q3 and Nine Months Ended December 31, 2025
Mold-Tek Packaging Limited has officially released its financial results for the third quarter and the nine-month period ending December 31, 2025. The announcement follows the board's review of the company's performance for the 2025-26 fiscal year. While the specific financial figures were not detailed in the cover letter, the filing confirms the company's adherence to regulatory reporting timelines. Investors should refer to the full press release on the company's website for detailed revenue and profit metrics.
முக்கிய அம்சங்கள்
Financial results for the quarter ended December 31, 2025, have been formally submitted to exchanges.Performance data for the nine-month period of FY 2025-26 is now available for investor review.The company maintained compliance with Regulation 30 of SEBI (LODR) Regulations, 2015.The disclosure was submitted to both BSE and NSE on February 09, 2026.
👀 கவனிக்க வேண்டியவை
Investors should analyze the detailed financial statements for volume growth and margin trends in the rigid packaging segment. Compare the Q3 performance against historical seasonal trends and industry peers.
Mold-Tek Packaging 9M Net Profit Up 18%; Pharma Sales Grow 5x; Signs MoU with Swiggy
Mold-Tek Packaging reported a steady Q3 FY26 with a 5.2% YoY increase in net profit to ₹14.35 crores, while 9-month (9M) net profit grew 17.95% to ₹52.23 crores. The company's Pharma segment showed exceptional performance, growing 500% over the last 9 months, with revenue projections of ₹50-55 crores for the next fiscal year. Strategic developments include a new MoU with Swiggy for restaurant packaging and a partnership with UK-based Vibe Generation Holdings for high-precision closures targeting a ₹250 crore revenue potential over 5 years. Operational efficiency is being addressed through the consolidation of manufacturing units in Hyderabad and a new facility for Grasim Industries.
முக்கிய அம்சங்கள்
9M FY26 Net Profit increased by 17.95% YoY to ₹52.23 crores; EBITDA grew 19.83% to ₹125.55 crores.Pharma segment volume grew 5x in 9 months, with commercial orders starting from MNCs like MSN and Laurus.Signed MoU with Swiggy to supply packaging solutions to its restaurant partners, expanding reach in the QSR segment.Entered MoU with Vibe Generation Holdings (UK) for high-precision caps, targeting ₹250 crore revenue in 5 years.Consolidating Hyderabad manufacturing units from six down to two/three to optimize administrative and logistics costs.
👀 கவனிக்க வேண்டியவை
Investors should monitor the scaling of the high-margin Pharma and Food/FMCG segments which are driving the improved product mix. The strategic MoUs with Swiggy and Vibe Generation provide strong visibility for future volume growth and market expansion.
Meghmani Organics Q3 FY26: Standalone PAT at ₹22 Cr; TiO2 Plant Shut Down to Curb Losses
Meghmani Organics reported a standalone revenue of ₹485 crores and a PAT of ₹22 crores for Q3 FY26, with the Crop Protection segment contributing 79% of revenue. The consolidated performance was impacted by the Titanium Dioxide (TiO2) segment, which faced high raw material costs and the withdrawal of anti-dumping duties, leading to a temporary plant shutdown. While 9M FY26 consolidated PAT turned positive at ₹21 crores compared to a loss last year, export volumes faced pressure due to US trade policy uncertainties. Management remains focused on debt reduction, having repaid ₹128 crores year-to-date.
முக்கிய அம்சங்கள்
Standalone Q3 FY26 revenue reached ₹485 crores with an EBITDA margin of 10.6%.Crop Protection segment EBITDA margin stood at 15.3% despite a 14% volume decline due to export headwinds.Consolidated 9M FY26 PAT improved to ₹21 crores from a loss of ₹30 crores in the prior year period.TiO2 plant temporarily shut down to mitigate losses following the withdrawal of anti-dumping duties by the Finance Ministry.Consolidated debt stands at ₹783 crores with a debt-to-equity ratio of 0.51 as of December 31, 2025.
👀 கவனிக்க வேண்டியவை
Investors should closely monitor the re-imposition of anti-dumping duties on TiO2 and the stabilization of US trade policies as primary recovery triggers. The stock remains a 'Watch' until the Pigment and TiO2 segments demonstrate sustainable margin improvement and operational stability.
Meghmani Organics Q3 FY26 Net Profit Declines 26% YoY to ₹22.3 Crore
Meghmani Organics reported a weak Q3 FY26 with standalone revenue declining 13% YoY to ₹484.9 crore and net profit falling 26% to ₹22.3 crore. The performance was primarily impacted by softer export demand due to US trade policy uncertainty and low capacity utilization in the Pigments segment at 38%. Despite the quarterly slowdown, the 9M FY26 performance remains strong with net profit surging 226% YoY to ₹105.7 crore. Management expects recovery through the re-imposition of Anti-Dumping Duties on TiO2 and normalization of raw material costs.
முக்கிய அம்சங்கள்
Q3 FY26 Revenue from Operations fell 13% YoY to ₹484.9 crore compared to ₹558.0 crore.Net Profit for the quarter dropped 26% YoY to ₹22.3 crore with margins shrinking to 4.6%.Pigments segment struggled significantly with EBITDA of only ₹0.7 crore and 38% capacity utilization.Crop Protection segment remained the mainstay, contributing 79% of revenue with 66% capacity utilization.9M FY26 cumulative performance remains positive with EBITDA up 75% YoY to ₹202.5 crore.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution as the company faces immediate headwinds in export markets and the Pigments division. Monitor the status of Anti-Dumping Duty on TiO2 and global demand recovery before increasing exposure.
Meghmani Organics Q3 FY26 Revenue Drops 13% YoY to ₹484.9 Cr; EBITDA at ₹51.5 Cr
Meghmani Organics Limited (MOL) reported a 13% year-on-year decline in standalone revenue for Q3 FY26, totaling ₹484.9 crore. EBITDA also decreased to ₹51.5 crore from ₹60.4 crore in the previous year's corresponding quarter. The Crop Protection segment remains the primary revenue driver, contributing 79% of the total revenue with an EBITDA margin of 15.3%. The company is currently focusing on strategic expansions in Titanium Dioxide (TiO2) and Nano Urea to diversify its portfolio and reduce reliance on traditional segments.
முக்கிய அம்சங்கள்
Standalone revenue from operations decreased 13% YoY to ₹484.9 crore in Q3 FY26.Crop Protection segment revenue stood at ₹382.1 crore, contributing 79% of the total mix.Exports remain critical, accounting for 87% of Crop Protection and 80% of Pigment revenue streams.The company has an installed capacity of 5 crore bottles per year for its new Nano Urea liquid fertilizer.MOL is positioning its Titanium Dioxide (TiO2) business as a major import substitute, targeting a market where 79% of supply is currently imported.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution due to the decline in quarterly revenue and EBITDA, suggesting near-term headwinds in core segments. Monitor the ramp-up and margin contribution from the new Nano Urea and TiO2 projects as they are critical for future growth.
Meghmani Organics Q3 FY26: Consolidated Revenue Falls 10.5% YoY to ₹508.7 Cr, Posts ₹3.5 Cr Net Loss
Meghmani Organics reported a weak performance for Q3 FY26, with consolidated revenue declining 10.5% YoY to ₹50,873.71 Lakhs. The company recorded a consolidated net loss of ₹352.83 Lakhs, a sharp reversal from the ₹1,155.32 Lakhs profit in the preceding quarter. While the Agrochemicals segment remains profitable on a standalone basis, the Pigments segment reported a loss of ₹134.92 Lakhs. Additionally, the board approved the re-appointment of three independent directors for a second three-year term starting May 2026.
முக்கிய அம்சங்கள்
Consolidated Revenue from operations fell 10.5% YoY to ₹50,873.71 Lakhs from ₹56,851.10 Lakhs.Reported a consolidated Net Loss of ₹352.83 Lakhs compared to a profit of ₹1,155.32 Lakhs in Q2 FY26.Standalone Agrochemicals segment revenue stood at ₹38,210.07 Lakhs, contributing ₹5,206.61 Lakhs in segment profit.Standalone Pigments segment reported a loss of ₹134.92 Lakhs on revenue of ₹10,283.55 Lakhs.Consolidated Finance costs rose to ₹1,513.01 Lakhs from ₹1,288.48 Lakhs in the year-ago quarter.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution as the company continues to face profitability challenges at the consolidated level and weakness in the Pigments division. Monitor the Agrochemical segment's ability to sustain margins amid rising finance costs and global demand volatility.
Mold-Tek Packaging Receives ₹4.84 Crore Income Tax Demand Notice for AY 2022-23
Mold-Tek Packaging Limited has received a demand notice from the Income Tax Department for the assessment year 2022-23. The notice, issued under Section 156 of the Income Tax Act, seeks an additional tax payment of ₹4.84 crore. The company received this communication on January 20, 2026, and has stated that it intends to contest the demand. Management plans to file a response or appeal with the Appellate Tribunal, Bangalore, within the 60-day deadline.
முக்கிய அம்சங்கள்
Tax demand amounting to ₹4,83,92,880 (approx. ₹4.84 crore) for Assessment Year 2022-23.Notice received from the Income Tax Department on January 20, 2026.Company intends to file an appeal or submission within the prescribed 60-day period.Matter will be reviewed and presented before the Appellate Tribunal, Bangalore.
👀 கவனிக்க வேண்டியவை
Investors should monitor the progress of the tax appeal as a final unfavorable ruling would result in a cash outflow of ₹4.84 crore. No immediate action is required as the company is actively contesting the claim.
Meghmani Organics to Acquire 26% Stake in Pro-Zeal Green Power for 3.30 MW Hybrid Energy
Meghmani Organics Limited (MOL) has entered into an agreement to acquire a minimum 26% stake in Pro-Zeal Green Power Fifteen Private Limited for a cash consideration of Rs. 3.63 Crores. This strategic investment is designed to secure 3.30 MW of Wind-Solar Hybrid (WSH) power for captive consumption at its Gujarat facilities. The acquisition, involving both equity and compulsory convertible debentures, is expected to be completed within 6-9 months. This move supports the company's sustainability goals and aims to optimize long-term energy costs through renewable sources.
முக்கிய அம்சங்கள்
Investment of Rs. 3.63 Crores for a minimum 26% stake in the renewable energy entitySecures 3.30 MW Wind-Solar Hybrid (WSH) power capacity as a captive consumerTransaction structure involves a 26:74 ratio between MOL and Prozeal Green Power Private LimitedAcquisition timeline set for completion within the next 6 to 9 monthsInvestment will be made through cash for Equity Shares and Compulsory Convertible Debentures
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive step toward ESG compliance and operational cost management. While the investment size is small relative to the company's market cap, it demonstrates a commitment to securing stable renewable energy supplies.
Meghmani Organics Releases FY25 Sustainability Report; Renewable Energy Use Rises to 39.03%
Meghmani Organics Limited (MOL) has released its inaugural Sustainability Report for FY 2024-25, highlighting a significant shift toward green energy with renewable electricity consumption reaching 39.03%, up from 32.4% the previous year. The company has set a long-term target to exceed 50% renewable energy by FY 2029-30 and aims for a 5% reduction in specific energy and freshwater use by March 2027. Operational efficiencies were noted with specific energy consumption dropping from 14.77 GJ/MT to 13.14 GJ/MT. These ESG initiatives, including Responsible Care accreditation and EcoVadis certification, position the company favorably for global supply chain integration.
முக்கிய அம்சங்கள்
Renewable energy consumption increased to 39.03% in FY25, with a target of 50% by FY30.Specific energy consumption reduced by 11% from 14.77 GJ/MT to 13.14 GJ/MT.Specific water consumption decreased from 11.23 KL/MT to 10.15 KL/MT.Specific bromine consumption improved from 0.225 kg/kg to 0.208 kg/kg of production.Company aims for Zero Reportable Accidents by 2025-26 and an EcoVadis score of 75 by FY26.
👀 கவனிக்க வேண்டியவை
Investors should view these improvements in resource efficiency and ESG compliance as a sign of operational maturity and risk mitigation. Monitor the progress toward the 50% renewable energy goal as it could lead to long-term cost savings and better global market access.
Anmol India: Ripan Kumar Goyal appointed as Non-Executive Independent Director
Anmol India Limited's board meeting on December 03, 2025, approved the appointment of Mr. Ripan Kumar Goyal (DIN: 11397550) as a Non-Executive Independent Director. This appointment is subject to shareholder approval at an Extra Ordinary General Meeting (EGM). The board meeting commenced at 11:00 A.M. and concluded at 12:15 P.M.
முக்கிய அம்சங்கள்
Mr. Ripan Kumar Goyal (DIN: 11397550) appointed as Non-executive Independent DirectorBoard meeting held on December 03, 2025Board meeting commenced at 11.00 A.M. and concluded at 12.15 P.M.
👀 கவனிக்க வேண்டியவை
Investors should monitor the upcoming Extra Ordinary General Meeting (EGM) for shareholder approval of the director appointment. Review Mr. Goyal's background and experience to assess potential impact.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
